Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: VietnámFázis nélkül

Adapting An Evidence-Based Intervention To Improve HIV Testing And PrEP Uptake In Vietnam

A legfontosabb adatok

Ki végzi
Hanoi Medical University
Hol
Hanoi (Vietnám)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
124 fő, tervezett
Kezdés
2025. jan. 15.
Várható befejezés
2029. aug. 31.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
A vizsgált kezelések
  • Mobile app
A regiszteradat frissítve
2025. augusztus 22.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat 18-24 éves, Hanoiban élő vietnami fiatal férfiakat keres, akik férfiakkal létesítenek szexuális kapcsolatot, és HIV-negatívak vagy nem ismerik a HIV-státuszukat. Egy mobilalkalmazást próbálnak ki a HIV-tesztelés és a PrEP használatának javítására. Egészségügyi dolgozók is csatlakozhatnak.

Életkor
Fiatal férfiak: 18-24 év. Egészségügyi dolgozók: a korhatárt a rekord nem írja le (legalább 18 év).
Nem
Férfiakkal szexuális kapcsolatot létesítő fiatal férfiak. A szakemberekre nemi megkötés nincs.
A betegség stádiuma
Nem betegségvizsgálat. A fiatal férfiak HIV-negatívak vagy a HIV-státuszuk ismeretlen.
Korábbi kezelés
A fő vizsgálatban nem csatlakozhat, aki jelenleg PrEP-et (megelőző gyógyszert) szed, vagy más HIV-tesztelési vagy PrEP programban vesz részt.
Biomarker vagy leletérték
HIV-negatív vagy ismeretlen HIV-státusz.

A részvétel fő kizáró okai

  • Az elmúlt 6 hónapban férfival végzett anális szex szükséges, aki nem számol be erről, nem csatlakozhat
  • Nincs okostelefonja
  • Nem Hanoiban él
  • Jelenleg PrEP-et szed (fő vizsgálat)
  • Nem adja meg az elérhetőségét

A regiszter feltételei, szó szerint

Mind a 4 feltétel megnézéseKevesebb

Ki vehet részt

  • Young men who have sex with men (YMSM):; Theater testing. YMSM are eligible if they (1) are 18-24 years old Vietnamese male; (2) report having anal intercourse with another man in the last 6 months; (3) are HIV negative or of unknown HIV status; (4) own a smartphone; (5) currently live in Hanoi, (6) are able to read and understand Vietnamese without assistance, and (7) are willing to provide informed consent; Beta testing. Eligibility is similar to theater testing. Randomized controlled trial (RCT). YMSM are eligible if they (1) are 18-24 years old Vietnamese male; (2) report having anal intercourse with another man in the last 6 months; (3) are HIV negative or of unknown HIV status; (4) own a smartphone; (5) currently live in Hanoi, (6) are able to read and understand Vietnamese without assistance, and (7) are willing to provide informed consent and (8) are not being currently on pre-exposure prophylaxis (PrEP)
  • Other key stakeholders:; Eligibility criteria of this group are (1) having worked with MSM-related health issues at an HIV/PrEP clinic or community-based organizations (CBO) for at least 6 months and (2) willingness to provide informed consent

Ki nem vehet részt

  • Young men who have sex with men (YMSM):; Theater testing. None Beta testing. Participants will be deemed ineligible if they are unwilling to provide contact information; Randomized controlled trial. Exclusion criteria include (1) unwilling to provide contact information; (2) currently enrolled in other HIV testing or PrEP program/intervention
  • Other key stakeholders: None

Helyszínek itt: Vietnám

  • Hanoi Medical UniversityHanoi, VietnámContact: Yen HoangRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Young men who have sex with men are experiencing an ongoing HIV epidemic in Vietnam, with an HIV prevalence of 12%. However, HIV testing and pre-exposure prophylaxis (PrEP) use among young men who have sex with men remain low. To improve HIV testing and PrEP use, mobile health (mHealth) interventions hold great promise to reach young men who have sex with men in low- and middle-income countries. HealthMindr, an evidence-based mHealth intervention developed in the United States for men who have sex with men, is an ideal option for adaptation for young men who have sex with men in Vietnam. The specific aims are to (1) Adapt the HealthMindr app to improve HIV testing and PrEP uptake among young men who have sex with men in Vietnam; (2) Examine acceptability, feasibility and preliminary effectiveness of the adapted app among young men who have sex with men in Vietnam and (3) Explore barriers and facilitators of implementing the adapted app among young men who have sex with men in Vietnam. In Aim 1, theater testing will be conducted through focus group discussions with young men who have sex with men and key other stakeholders, including health officials, clinic staff and community-based organizations. Theater testing data will be used to refine the app for beta testing. During beta testing, a small group of young men who have sex with men will use the app for 30 days, then complete an online survey and an exit interview to rate the app's usability, provide their perspectives of the app and report any other areas for improvement. App analytics will also be collected to understand whether and how the app is used. In Aim 2, the adapted app with be tested among young men who have sex with men through a randomized controlled design. Young men who have sex with men will be randomized into the intervention or control arm (1:1 ratio). The intervention arm will have full access to the app for 3 months, while the control group will receive standard-of-care HIV services. Key app features include HIV test planning, risk and PrEP eligibility assessment, ordering of free condoms and HIV test kits, information about PrEP, and PrEP provider and HIV testing locations. HIV testing and PrEP use will be assessed at baseline and 3 months and compared between groups. A mixed methods approach will be used to evaluate app acceptability and feasibility. Quantitative data on acceptability and feasibility will be collected through the 3-month online survey, while qualitative data will be collected through in-depth interviews with a subset of young men who have sex with men in the intervention arm and other key stakeholders. In Aim 3, through the same qualitative study as Aim 2, factors that influence the implementation of the app will be explored. Determinants from seven domains will be identified: condition, technology, value proposition, adopter system, health organization, wider system and embedding/adaption over time. Only when mHealth interventions are both effective and adopted can they maximize their potential to reduce HIV incidence among target populations. This proposal will generate data for designing a full-scale hybrid type 1 effectiveness-implementation trial to test the adapted app and identify implementation strategies to address the barriers of app implementation in low and middle-income countries.

A vizsgálat 2 csoportja

  • InterventionA vizsgált kezelés

    Those assigned to the intervention arm will receive access to the adapted HealthMindr app with key features, including HIV test planning, initial risk/PrEP eligibility assessment, ordering of free condoms and HIV test kits, information about PrEP, PrEP provider and HIV testing locations, and any additional features added through the adaptation process. The staff will help participants download the app and walk them through its use during the study visit. These participants will be encouraged to use the app for a period of 3 months. In addition, participants will be provided standard-of-care HIV prevention information upon enrollment at the study site by a study staff, which includes written prevention materials for HIV testing and referrals to local HIV prevention services. Anyone who seroconverts during the study period will be referred to appropriate HIV treatment services.

    Kezelés: Mobile app

  • ControlNincs vizsgálati kezelés, összehasonlításként

    Participants randomized to the control arm will be provided standard-of-care HIV prevention information upon enrollment at the study site by a study staff, which includes written prevention materials for HIV testing and referrals to local HIV prevention services. Anyone who seroconverts during the study period will be referred to appropriate HIV treatment services.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 12.
A regiszteradat frissítve
2025. augusztus 22.